199 related articles for article (PubMed ID: 15950253)
1. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.
Mische CC; Yuan W; Strack B; Craig S; Farzan M; Sodroski J
Virology; 2005 Jul; 338(1):133-43. PubMed ID: 15950253
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
3. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
[TBL] [Abstract][Full Text] [Related]
4. The p17 stretch at the N terminus of the HIV1-gag precursor and the intracellular part of HIV1-env gp41 have heptad repeat regions in their sequences that could bind to each other in a coiled coil.
Wachinger G; Nitschko H; Wachinger M; von der Helm K
Protein Seq Data Anal; 1991 Dec; 4(6):375-6. PubMed ID: 1812494
[No Abstract] [Full Text] [Related]
5. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
6. Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model.
Shu W; Ji H; Lu M
Biochemistry; 1999 Apr; 38(17):5378-85. PubMed ID: 10220324
[TBL] [Abstract][Full Text] [Related]
7. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
Wexler-Cohen Y; Sackett K; Shai Y
Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
[TBL] [Abstract][Full Text] [Related]
8. Atomic structure of the ectodomain from HIV-1 gp41.
Weissenhorn W; Dessen A; Harrison SC; Skehel JJ; Wiley DC
Nature; 1997 May; 387(6631):426-30. PubMed ID: 9163431
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
[TBL] [Abstract][Full Text] [Related]
10. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
11. Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interaction.
Sen J; Yan T; Wang J; Rong L; Tao L; Caffrey M
Biochemistry; 2010 Jun; 49(24):5057-65. PubMed ID: 20481578
[TBL] [Abstract][Full Text] [Related]
12. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
[TBL] [Abstract][Full Text] [Related]
14. The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization.
Wingfield PT; Stahl SJ; Kaufman J; Zlotnick A; Hyde CC; Gronenborn AM; Clore GM
Protein Sci; 1997 Aug; 6(8):1653-60. PubMed ID: 9260278
[TBL] [Abstract][Full Text] [Related]
15. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
Kesavardhana S; Varadarajan R
J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
[TBL] [Abstract][Full Text] [Related]
16. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
[TBL] [Abstract][Full Text] [Related]
17. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
Jiang S; Debnath AK
Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
[TBL] [Abstract][Full Text] [Related]
18. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
Mo H; Konstantinidis AK; Stewart KD; Dekhtyar T; Ng T; Swift K; Matayoshi ED; Kati W; Kohlbrenner W; Molla A
Virology; 2004 Nov; 329(2):319-27. PubMed ID: 15518811
[TBL] [Abstract][Full Text] [Related]
19. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
[TBL] [Abstract][Full Text] [Related]
20. Artificial ion channel biosensor in human immunodeficiency virus gp41 drug sensing.
Hou Y; Gochin M
Anal Chem; 2008 Aug; 80(15):5924-9. PubMed ID: 18590277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
